最終更新日：2025/11/30
Following years of research, the biotech startup announced the deorphanization of its rare-disease compound, opening the way for wider clinical trials.
正解を見る
Following years of research, the biotech startup announced the deorphanization of its rare-disease compound, opening the way for wider clinical trials.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
